Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Regelgeving en recht · 20-12-20131 min lezen
Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/762,543, entitled "Antibody-Dependent Cellular Cytoxicity (ADCC)- Mediating Antibodies," filed on February 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Oorspronkelijke brontaal: Federal Register — All DocumentsOrigineel bericht openen →